 |
| |
| Jul-29-19 | Downgrade |
Robert W. Baird |
Outperform → Neutral |
$66 |
|
| Feb-12-19 | Downgrade |
Jefferies |
Buy → Hold |
$60 |
|
| Feb-08-19 | Downgrade |
Needham |
Buy → Hold |
|
|
| Oct-31-18 | Reiterated |
Needham |
Buy |
$80 → $75 |
|
| Oct-17-18 | Reiterated |
Needham |
Buy |
$67 → $80 |
|
| Sep-27-18 | Upgrade |
Robert W. Baird |
Neutral → Outperform |
|
|
| Aug-01-18 | Reiterated |
Needham |
Buy |
$69 → $67 |
|
| Jun-27-18 | Downgrade |
BofA/Merrill |
Neutral → Underperform |
|
|
| Jun-21-18 | Downgrade |
JP Morgan |
Overweight → Neutral |
|
|
| Jun-01-18 | Initiated |
Cantor Fitzgerald |
Neutral |
|
|
| May-02-18 | Reiterated |
Needham |
Buy |
$70 → $69 |
|
| Apr-04-18 | Initiated |
Goldman |
Neutral |
$47 |
|
| Feb-27-18 | Reiterated |
Needham |
Buy |
$71 → $70 |
|
| Feb-01-18 | Downgrade |
Leerink Partners |
Outperform → Mkt Perform |
|
|
| Jan-17-18 | Downgrade |
Wells Fargo |
Outperform → Market Perform |
|
|
| Jan-04-18 | Upgrade |
Needham |
Underperform → Buy |
$71 |
|
| Nov-10-17 | Reiterated |
RBC Capital Mkts |
Outperform |
$75 → $70 |
|
| Oct-25-17 | Reiterated |
Canaccord Genuity |
Buy |
$75 → $70 |
|
| Sep-07-17 | Initiated |
BTIG Research |
Buy |
$82 |
|
| Aug-28-17 | Downgrade |
Needham |
Hold → Underperform |
|
|
|
|
| Aug-16-19 09:52AM | Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now Zacks |
| 09:51AM | QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results Zacks |
| Aug-15-19 09:13AM | Baxter's PrisMax Adopted by Hamilton Health Care System Zacks |
| Aug-14-19 12:14PM | CVS Health Banks on Health Care Benefit Prospects Amid Woes Zacks |
| 09:40AM | ResMed (RMD) Hits a New 52-Week High: What's Driving It? Zacks |
| 09:35AM | Here's Why You Should Hold Onto Insulet (PODD) Stock for Now Zacks |
| 08:30AM | NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening PR Newswire |
| Aug-13-19 10:18AM | Boston Scientific Rides on New Products Amid Dull Pacer Sales Zacks |
| 09:35AM | Baxter (BAX) Hits 52-Week High, Can the Run Continue? Zacks |
| 09:10AM | Canopy Growth Set to Acquire Beckley Canopy Therapeutics Zacks |
| Aug-12-19 08:41AM | National Vision (EYE) Q2 Earnings Lag Estimates, Margins Down Zacks |
| Aug-09-19 02:26PM | Why NuVasive Stock Gained 14% in July Motley Fool |
| 07:32AM | Haemonetics (HAE) Beats on Q1 Earnings, Raises '19 EPS View Zacks |
| Aug-08-19 06:00AM | NuVasive Presents Long-Term Strategy and Financial Outlook at 2019 Investor Day PR Newswire |
| Aug-06-19 09:30AM | NUVA vs. RMD: Which Stock Is the Better Value Option? Zacks |
| Aug-02-19 07:54AM | Will NuVasive Continue to Surge Higher? Zacks |
| Aug-01-19 02:07PM | Is NuVasive (NASDAQ:NUVA) Using Too Much Debt? Simply Wall St. |
| Jul-31-19 01:15PM | Why NuVasive Stock Is Shooting Higher Today Motley Fool +10.96% |
| 01:11PM | Edited Transcript of NUVA earnings conference call or presentation 30-Jul-19 8:30pm GMT Thomson Reuters StreetEvents |
| 09:23AM | NuVasive Inc (NUVA) Q2 2019 Earnings Call Transcript Motley Fool |
| 09:08AM | NuVasive (NUVA) Earnings and Revenues Beat Estimates in Q2 Zacks |
| 08:23AM | NuVasive Sees a Healthier Future Motley Fool |
| Jul-30-19 06:05PM | NuVasive (NUVA) Tops Q2 Earnings and Revenue Estimates Zacks |
| 04:02PM | NuVasive Announces Second Quarter 2019 Financial Results PR Newswire |
| 02:30PM | NuVasive, Inc. to Host Earnings Call ACCESSWIRE |
| 07:02AM | Buy 6 Top Stocks Set to Beat on Earnings in Q2 Today Zacks |
| Jul-26-19 10:10AM | Why the Earnings Surprise Streak Could Continue for NuVasive (NUVA) Zacks |
| Jul-23-19 10:32AM | NuVasive (NUVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks |
| Jul-17-19 09:17AM | Henry Schein Closes Acquisition of Elite Computer Italia Zacks |
| 08:51AM | NextGen Inks Deal With Appriss Health, Boosts EHR System Zacks |
| Jul-16-19 08:47AM | Intuitive Surgical to Boost da Vinci Platform With Buyout Zacks |
| 08:39AM | Chemed's Roto-Rooter & VITAS Robust, Acuity Mix Shift Weak Zacks |
| 07:59AM | Masimo (MASI) Hits a 52-Week High on Solid Growth Drivers Zacks |
| 07:45AM | Abbott MitraClip G4 Gets FDA Nod, Valve Repair Options Expand Zacks |
| Jul-15-19 04:05PM | NuVasive Announces Conference Call and Webcast of Second Quarter 2019 Results PR Newswire |
| 09:12AM | ABT or BIO: Which Stock Has Better Potential Right Now? Zacks |
| 08:33AM | Here's Why You Should Hold Onto Neogen (NEOG) Stock Now Zacks |
| 08:30AM | Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D. GlobeNewswire |
| Jul-12-19 08:54AM | TFX or STE: Which is a Better Investment Pick Right Now? Zacks |
| Jul-11-19 08:30AM | NuVasive to Participate as Double Diamond Sponsor at 2019 International Meeting on Advanced Spine Techniques PR Newswire |
| 07:19AM | NuVasive (NUVA) Launches Pulse Integrated Technology Platform Zacks |
| Jul-10-19 08:30AM | NuVasive Launches Pulse-The First Integrated Technology Platform to Enable Better Spine Surgery PR Newswire |
| 06:10AM | At US$55.78, Is It Time To Put NuVasive, Inc. (NASDAQ:NUVA) On Your Watch List? Simply Wall St. |
| Jun-20-19 12:09PM | Heres What Hedge Funds Think About NuVasive, Inc. (NUVA) Insider Monkey |
| 06:59AM | Was NuVasive, Inc.'s (NASDAQ:NUVA) Earnings Growth Better Than The Industry's? Simply Wall St. |
| Jun-18-19 10:22AM | NuVasive Grows on Strong Product Adoption Amid Pricing Woe Zacks |
| 07:27AM | NuVasive Launches Titanium Spine Implant Modulus TLIF-O Zacks |
| Jun-17-19 08:30AM | NuVasive Expands Advanced Materials Science Portfolio with Launch of Porous Titanium Spine Implant for Transforaminal Lumbar Interbody Fusion PR Newswire |
| Jun-12-19 08:30AM | NuVasive LessRay® Platform Wins Gold at 2019 Medical Design Excellence Awards PR Newswire |
| May-31-19 09:31AM | Why Is NuVasive (NUVA) Down 3.9% Since Last Earnings Report? Zacks |
| May-30-19 08:30AM | NuVasive SpineTRACK Registry Successfully Meets 2018 Medicare Reporting Requirements For Merit-based Incentive Payments System PR Newswire |
| May-29-19 09:47AM | Is NuVasive, Inc. (NASDAQ:NUVA) A Financially Sound Company? Simply Wall St. |
| May-28-19 03:39PM | Edited Transcript of NUVA earnings conference call or presentation 1-May-19 8:30pm GMT Thomson Reuters StreetEvents |
| 08:55AM | Here's Why You Should Retain NuVasive (NUVA) Stock for Now Zacks |
| May-14-19 09:30AM | VREX vs. NUVA: Which Stock Is the Better Value Option? Zacks |
| 08:30AM | NuVasive To Participate As Global Partner At 12th Annual Society Of Lateral Access Surgery Meeting PR Newswire |
| May-06-19 04:05PM | NuVasive To Present At The Bank of America Merrill Lynch Healthcare Conference 2019 PR Newswire |
| 08:20AM | How NuVasive, Inc. (NASDAQ:NUVA) Can Impact Your Portfolio Volatility Simply Wall St. |
| May-02-19 11:37AM | NuVasive (NUVA) Q1 Earnings Top Estimates, Margins Strong Zacks |
| 05:35AM | NuVasive Inc (NUVA) Q1 2019 Earnings Call Transcript Motley Fool |
| May-01-19 08:05PM | NuVasive Straightens Up to Start 2019 Motley Fool |
| 06:05PM | NuVasive (NUVA) Q1 Earnings and Revenues Top Estimates Zacks |
| 04:55PM | NuVasive: 1Q Earnings Snapshot Associated Press |
| 04:02PM | NuVasive Announces First Quarter 2019 Financial Results PR Newswire |
| 11:53AM | A Preview Of NuVasive's Q1 Earnings Benzinga |
| Apr-29-19 09:45AM | Is NuVasive, Inc. (NUVA) A Good Stock To Buy? Insider Monkey |
| Apr-24-19 10:33AM | NuVasive (NUVA) Reports Next Week: Wall Street Expects Earnings Growth Zacks |
| Apr-22-19 08:30AM | Clinical Study Demonstrates NuVasive Cohere® Porous PEEK Spinal Interbody Promotes Improved Early Outcomes Over Structural Allograft And Smooth PEEK PR Newswire |
| Apr-15-19 04:05PM | NuVasive Announces Conference Call And Webcast Of First Quarter 2019 Results PR Newswire |
| Apr-11-19 05:30AM | Nuvasive Advances Lateral Single-Position Surgery With Introduction Of X360 System At AANS 2019 PR Newswire |
| Apr-05-19 08:30AM | NuVasive LessRay® Platform Wins Top Honor At 2019 Edison Awards PR Newswire |
| Apr-02-19 10:50AM | NuVasive (NUVA) Completes First COHERE XLIF Case in U.S. Zacks |
| Apr-01-19 08:30AM | NuVasive Proprietary Porous PEEK Technology Used In First XLIF® Spine Surgery Cases PR Newswire |
| Mar-22-19 09:30AM | NuVasive (NUVA) Down 1% Since Last Earnings Report: Can It Rebound? Zacks |
| Mar-12-19 03:30PM | Options Bears Jump on Battered NuVasive Stock Schaeffer's Investment Research -5.84% |
| Mar-06-19 04:05PM | NuVasive To Feature Lateral Single-Position Surgery And Surgical Intelligence At Spine Summit 2019 PR Newswire |
| 01:39PM | Why NuVasive Stock Rose 18% in February Motley Fool |
| 07:55AM | Research Report Identifies E*TRADE Financial, Kennedy-Wilson, Alteryx, PTC Therapeutics, Ocean Power Technologies, and NuVasive with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire |
| Mar-05-19 04:05PM | NuVasive To Participate In Cowen And Company 39th Annual Health Care Conference PR Newswire |
| Feb-25-19 02:11AM | Edited Transcript of NUVA earnings conference call or presentation 20-Feb-19 9:30pm GMT Thomson Reuters StreetEvents |
| Feb-22-19 07:50AM | NuVasive (NUVA) Q4 Earnings Beat Estimates, Margins Fall Zacks |
| Feb-21-19 04:05PM | NuVasive To Present At 8th Annual Leerink Partners Global Healthcare Conference PR Newswire |
| 02:17PM | NuVasive (NUVA) Q4 2018 Earnings Conference Call Transcript Motley Fool |
| Feb-20-19 06:21PM | NuVasive Overcomes Industry Headwinds to Finish 2018 Strong Motley Fool |
| 05:40PM | NuVasive (NUVA) Q4 Earnings and Revenues Top Estimates Zacks |
| 04:34PM | NuVasive: 4Q Earnings Snapshot Associated Press |
| 04:02PM | NuVasive Reports Fourth Quarter And Full Year 2018 Financial Results PR Newswire |
| 02:30PM | NuVasive, Inc. to Host Earnings Call ACCESSWIRE |
| Feb-19-19 08:30AM | NuVasive's Proprietary Magnetic Implant System To Be Used In First-Of-Its-Kind, All-Internal Bone Transport System PR Newswire |
| Feb-13-19 10:31AM | NuVasive (NUVA) Earnings Expected to Grow: Should You Buy? Zacks |
| 07:50AM | New Research: Key Drivers of Growth for Plains Group Holdings, Cooper Tire & Rubber, NuVasive, Envestnet, Pacific Ethanol, and Mistras Group Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire |
| Feb-12-19 10:21AM | Jefferies Downgrades NuVasive, Says M&A Unlikely To Materialize Benzinga |
| 12:00AM | [$$] Morgan Stanley tests M&A waters with millennial millionaires play Financial Times |
| Feb-11-19 04:34PM | Why NuVasive, Avis Budget Group, and Insperity Jumped Today Motley Fool +13.26% |
| 04:20PM | NuVasive Stock Surges on Report of Smith & Nephew Interest TheStreet.com |
| 04:17PM | Medical Stock Pops On Potential $3 Billion Smith & Nephew Takeover Investor's Business Daily |
| 01:33PM | Heres why NuVasive, Inc.s (NASDAQ:NUVA) Returns On Capital Matters So Much Simply Wall St. |
| 11:44AM | NuVasive Stock Shoots Higher on Takeover Talk InvestorPlace |
| 10:45AM | Here's Why NuVasive Stock Is Soaring Today Motley Fool |
| 09:58AM | Smith & Nephew Drops on Report of Deal Talks With NuVasive Bloomberg |
|
|
|
|
| NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company's principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally-disruptive fashion. The company's biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and PRECICE, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| SISITSKY NATHANIEL | SVP & General Counsel | Jul 01 | Option Exercise | 0.00 | 1,710 | 0 | 9,957 | Jul 03 05:52 PM | | Rosenberg Donald J | Director | Jun 01 | Option Exercise | 0.00 | 3,230 | 0 | 9,193 | Jun 04 05:53 PM | | LUCIER GREGORY T | Director | May 22 | Option Exercise | 0.00 | 78,702 | 0 | 270,709 | May 24 05:53 PM | | Huennekens R Scott | Director | May 09 | Option Exercise | 0.00 | 1,360 | 0 | 1,360 | May 10 05:47 PM | | OHALLERAN MICHAEL D | Director | May 03 | Option Exercise | 0.00 | 3,230 | 0 | 18,816 | May 07 05:52 PM | | Link Matthew | President | May 02 | Sale | 62.00 | 10,100 | 626,200 | 83,143 | May 06 05:55 PM | | McClintock Paul | President, U.S. Commercial | Apr 01 | Option Exercise | 0.00 | 5,065 | 0 | 5,465 | Apr 03 05:54 PM | | SISITSKY NATHANIEL | SVP & General Counsel | Mar 01 | Option Exercise | 0.00 | 4,950 | 0 | 9,579 | Mar 05 05:57 PM | | Vitale Lucas | Chief Human Resources Officer | Mar 01 | Option Exercise | 0.00 | 3,992 | 0 | 6,799 | Mar 05 05:55 PM | | Link Matthew | President | Mar 01 | Option Exercise | 0.00 | 19,157 | 0 | 100,074 | Mar 05 05:48 PM | | LUCIER GREGORY T | Director | Mar 01 | Option Exercise | 0.00 | 79,814 | 0 | 230,776 | Mar 05 05:44 PM | | Link Matthew | President, Strat/Tech/Corp Dev | Dec 17 | Option Exercise | 34.82 | 500 | 17,410 | 79,616 | Dec 19 05:55 PM | | Link Matthew | President, Strat/Tech/Corp Dev | Nov 21 | Sale | 62.22 | 4,889 | 304,194 | 79,116 | Nov 26 05:57 PM | | Link Matthew | President, Strat/Tech/Corp Dev | Nov 19 | Sale | 62.02 | 1,382 | 85,712 | 84,005 | Nov 20 05:56 PM | | Link Matthew | President, Strat/Tech/Corp Dev | Nov 16 | Sale | 62.01 | 1,200 | 74,412 | 85,387 | Nov 20 05:56 PM |
|
|
|
|
|
|
